Therapeutic biliary endoscopy

Endoscopy

Volumn 35, Issue 2, 2003, Pages 156-163

  Fogel, E L ^a   Sherman, S ^a   Park, S H ^a   McHenry, L ^a   Lehman, G A ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABEXATE MESILATE; INTERLEUKIN 10; MIDAZOLAM; URSODEOXYCHOLIC ACID;

BALLOON DILATATION; BILE DUCT CARCINOMA; BILE DUCT INJURY; BILE DUCT OBSTRUCTION; BILIARY TRACT DISEASE; BILIARY TRACT DRAINAGE; BILIARY TRACT ENDOSCOPY; CATHETER; CHOLECYSTOTOMY; CLINICAL TRIAL; COMMON BILE DUCT STONE; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; ENDOSCOPIC THERAPY; HEALTH CARE COST; HUMAN; LAPAROSCOPIC SURGERY; LIVER TRANSPLANTATION; MALIGNANT NEOPLASTIC DISEASE; MANOMETRY; META ANALYSIS; OBSTRUCTIVE JAUNDICE; ODDI SPHINCTER DYSFUNCTION; PANCREATITIS; PHOTODYNAMIC THERAPY; PREOPERATIVE CARE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; SAMPLING; STENT;

BILIARY TRACT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLECYSTECTOMY, LAPAROSCOPIC; CONSTRICTION, PATHOLOGIC; HUMANS; PANCREATITIS; POSTOPERATIVE COMPLICATIONS; SPHINCTER OF ODDI;

EID: 0037315077     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37011     Document Type: Review

References (58)

1. Sandler RS, Everhart JE, Donowitz M et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-1511
2. Lang L. Panel issues ERCP recommendations. Gastroenterology 2002; 122: 601-602
3. Bergman JJ, Burgemeister L, Bruno MJ et al. Long-term follow-up after biliary stent placement for postoperative bile duct stenosis. Gastrointest Endosc 2001; 54: 154-161
4. Costamagna G, Pandolfi M, Mutignani M et al. Long-term results of endoscopic management of postoperative bile duct strictures with increasing numbers of stents. Gastrointest Endosc 2001; 54: 162-168
5. Draganov P, Hoffman B, Marsh W et al. Long-term outcome in patients with benign biliary strictures treated endoscopically with multiple stents. Gastrointest Endosc 2002; 55: 680-686
6. Singh N, Sherman S, Phillips SD et al. Outcome of endoscopic biliary stenting in chronic pancreatitis-induced common bile duct strictures. Gastrointest Endosc 2001; 53: AB94
7. Baluyut AR, Sherman S, Lehman GA et al. Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc 2001; 53: 308-312
8. Stiehl A, Rudolph G, Kloters-Plachky P et al. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: Outcome after endoscopic treatment. J Hepatol 2002; 36: 151-156
9. Linder S, Soderlund C. Endoscopic therapy in primary sclerosing cholangitis: Outcome of treatment and risk of cancer. Hepatogastroenterology 2001; 48: 387-392
10. Kaya M, De Groen PC, Angulo P et al. Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: The Mayo Clinic experience. Am J Gastroenterol 2001; 96: 1164-1169
11. Siqueira E, Schoen RE, Silverman W et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc 2002; 56: 40-47
12. Rerknimitr R, Sherman S, Fogel EL et al. Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: Endoscopic findings and results of therapy. Gastrointest Endosc 2002; 55: 224-231
13. Morelli J, Mulcahy HE, Willner IR et al. Endoscopic treatment of post-liver transplantation biliary leaks with stent placement across the leak site. Gastrointest Endosc 2001; 54: 471-475
14. DeBellis M, Fogel EL, Sherman S et al. Frequency of laparoscopic cholecystectomy injuries detected at ERCP: Eight-year experience at a tertiary referral center. Gastrointest Endosc 2002; 55: AB186
15. Chaudhary A, Manisegran M, Chandra A et al. How do bile duct injuries sustained during laparoscopic cholecystectomy differ from those during open cholecystectomy? J Laparoendosc Adv Surg Tech A 2001; 11: 187-191
16. Arnold JC, Benz C, Martin WR et al. Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: A prospective randomized pilot study. Endoscopy 2001; 33: 563-567
17. Komatsu Y, Fujita N, Maguchi H et al. Prospective randomized controlled trial of endoscopic sphincterotomy compared with endoscopic papillary balloon dilatation for bile duct stones: Short-term outcome and biliary symptoms in 6 months. Gastrointest Endosc 2002; 55: AB169
18. Aizawa T, Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilatation for removal of bile duct stones. Gastrointest Endosc 2001; 54: 209-213
19. Moon JH, Cho YD, Ryu CB et al. The role of percutaneous transhepatic papillary balloon dilatation in percutaneous choledochoscopic lithotomy. Gastrointest Endosc 2001; 54: 232-236
20. Yasuda I, Tomita E, Enya M et al. Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function? Gut 2001; 49: 686-691
21. Sugiyama M, Atomi Y. Medium-term effects of endoscopic papillary balloon dilation on gallbladder motility. Gastrointest Endosc 2001; 54: 459-463
22. Huibregtse K. Endoscopic balloon dilation for removal of bile duct stones: Special indications only. Endoscopy 2001; 33: 620-622
23. Sewnath ME, Karsten TM, Prins MH et al. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 2002; 236: 17-27
24. Arguedas MR, Heudebert GH et al. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: A cost-effectiveness analysis. Am J Gastroenterol 2002; 97: 898-904
25. Ferlitsch A, Oesterreicher C, Dumonceau JM et al. Diamonds stents for palliation of malignant bile duct obstruction: A prospective multicenter evaluation. Endoscopy 2001; 33: 645-650
26. Kim HS, Lee DK, Kim HG et al. Features of malignant biliary obstruction affecting the patency of metallic stents: A multicenter study. Gastrointest Endosc 2002; 55: 359-365
27. Isayama H, Komatsu Y, Tsujino T et al. Polyurethane-covered metal stent for management of distal malignant biliary obstruction. Gastrointest Endosc 2002; 55: 366-370
28. Weaver SA, Stacey BS, Hayward SJ et al. Endoscopic palliation and survival in malignant biliary obstruction. Dig Dis Sci 2001; 46: 2147-2153
29. Halm U, Schiefke, Fleig WE et al. Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: A prospective, randomized trial. Endoscopy 2001; 33: 491-494
30. Weickert U, Venzke T, Konig J et al. Why do bilioduodenal plastic stents become occluded? A clinical and pathological investigation on 100 consecutive patients. Endoscopy 2001; 33: 786-790
31. Catalano MF, Geenen JE, Lehman GA et al. "Tannenbaum" Teflon stents versus traditional polyethylene stents for treatment of malignant biliary stricture. Gastrointest Endosc 2002; 55: 354-358
32. Ortner ME, Giesse A, Caca K et al. Photodynamic therapy of non-resectable cholangiocarcinoma: A randomized prospective study - First results. Gastrointest Endosc 2001; 53: AB85
33. Zoepf T, Jakobs R, Arnold JC et al. Photodynamic therapy for palliation of nonresectable bile duct cancer: Preliminary results with a new diode laser system. Am J Gastroenterol 2001; 96: 2093-2097
34. Zoepf T, Jakobs R, Rosenbaum A et al. Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer. Gastrointest Endosc 2001; 54: 763-766
35. Kaw M, Singh S. Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-induced pancreatitis. Gastrointest Endosc 2001; 54: 435-440
36. Davière J, Moine O, Van Laethem JL et al. Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120: 498-505
37. McHenry L, Monroe P, Duckworth F et al. A randomized, double-blind pilot study of the efficacy of interleukin-10 (IL-10) in the prevention of post-ERCP pancreatitis. Am J Gastroenterol 2001; 96: S61-S62
38. Epstein MS, DeHaemer T, Praschak PM et al. Double-blind, placebo-controlled pilot study of the safety and activity of interleukin-10 (RHuIL-10) in the prevention of acute pancreatitis following endoscopic retrograde choalngiopancreatography (ERCP). Am J Gastroenterol 2001; 96: S85-S86
39. Manolakopoulos S, Avgerinos A, Vlachogiannakos J et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: A multicenter randomized controlled trial. Gastrointest Endosc 2002; 55: 470-475
40. Freeman ML, Cass OW, Dailey J. Dilation of high-grade pancreatic and biliary ductal strictures with small-caliber angioplasty balloons. Gastrointest Endosc 2001; 54: 89-92
41. Silverman WB, Thompson RA. Management of asymptomatically/minimally asymptomatic post-ERCP serum liver test elevations: First do no harm. Dig Dis Sci 2002; 47: 1498-1501
42. Enns R, Eloubeidi MA, Mergener K et al. ERCP-related perforations: Risk factors and management. Endoscopy 2002; 34: 293-298
43. Eisen GM, Baron TH, Dominitz JA et al. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002; 55: 775-779
44. 99mTc-Choletec) hepatobiliary scintigraphy in asymptomatic postcholecystectomy individuals: Assessment of specificity, interobserver reliability, and reproducibility. Am J Gastroenterol 2001; 96: 3106-3109
45. Thomas PD, Turner JG, Dodds BR et al. Use of (99m) Tc-DISIDA biliary scanning with morphine provocation for the detection of elevated sphincter of Oddi basal pressure. Gut 2000; 46: 838-841.
46. Cicala M, Habib FI, Vavassori P et al. Outcome of endoscopic sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction as predicted by manometry and quantitative choledochoscintigraphy. Gut 2002; 50: 665-668
47. Rosenblatt ML, Catalano MF, Alcocer E, Geenen JE. Comparison of sphincter of Oddi manometry, fatty meal sonography, and hepatobiliary scintigraphy in the diagnosis of sphincter of Oddi dysfunction. Gastrointest Endosc 2001; 54: 697-704
48. Hogan WJ. Hepatobiliary scintigraphy as the diagnostic test for sphincter of Oddi dysfunction: Pan the scan? Am J Gastroenterol 2002; 97: 1288-1291
49. Quallich LG, Stern MA, Rich M et al. Bile duct crystals do not contribute to sphincter of Oddi dysfunction. Gastrointest Endosc 2002; 55: 163-166
50. Di Francesco V, Mariani A, Angelini G et al. Effects of gabexate mesilate, a protease inhibitor, on human sphincter of Oddi motility. Dig Dis Sci 2002; 47: 741-745
51. Fazel A, Burton FR. A controlled study of the effect of midazolam on abnormal sphincter of Oddi motility. Gastrointest Endosc 2002; 55: 637-640
52. Fogel EL, Eversman D, Jamidar P et al. Sphincter of Oddi dysfunction: Pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002; 34: 280-285
53. Kaufman D, Widlus D, Lazinger M et al. Diagnostic accuracy of Simpson atherectomy catheter biopsy in detecting pancreaticobiliary malignancy. Am J Gastroenterol 2001; 96: 1054-1058
54. Mazzaglia P, Howell DA, Sheth SG et al. Clinical value of tissue sampling at ERCP. Gastrointest Endosc 2002; 55: AB170.
55. Farrell RJ, Jain AK, Brandwein SL et al. The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures. Gastrointest Endosc 2001; 54: 587-594
56. Heiss FW, Cimis RS, MacMillan Jr FP. Biliary sphincter scissor for precut access: Preliminary experience. Gastrointest Endosc 2002; 55: 719-722
57. Feitoza AB, Baron TH. Endoscopy and ERCP in the setting of previous upper GI tract surgery, 1: Reconstruction without alteration of pancreaticobiliary anatomy. Gastrointest Endosc 2001; 54: 743-749
58. Freeman ML, DiSario JA, Nelson DB et al. Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest Endosc 2001; 54: 425-434